SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 1 filers reported holding SERES THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $202 | -53.2% | 84,885 | -6.0% | 0.00% | -50.0% |
| Q2 2023 | $432 | -25.5% | 90,285 | -11.7% | 0.00% | 0.0% |
| Q1 2023 | $580 | +6.8% | 102,281 | +5.5% | 0.00% | 0.0% |
| Q4 2022 | $543 | -99.9% | 96,954 | +14.3% | 0.00% | 0.0% |
| Q3 2022 | $544,000 | +106.1% | 84,800 | +2.4% | 0.00% | +100.0% |
| Q2 2022 | $264,000 | -43.3% | 82,800 | +26.6% | 0.00% | -50.0% |
| Q1 2022 | $466,000 | +29.1% | 65,400 | +51.0% | 0.00% | +100.0% |
| Q4 2021 | $361,000 | +94.1% | 43,300 | +62.2% | 0.00% | 0.0% |
| Q3 2021 | $186,000 | – | 26,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |